Literature DB >> 21926608

Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia.

Ervin Pejo1, Yan Feng, Wei Chao, Joseph F Cotten, Ri Le Ge, Douglas E Raines.   

Abstract

OBJECTIVE: We developed a novel pyrrole analog of etomidate, (R)-ethyl 1-(1-phenylethyl)-1H-pyrrole-2-carboxylate (carboetomidate), which retains etomidate's desirable anesthetic and hemodynamic properties but lacks its potent inhibitory affect on adrenocorticotropic hormone-stimulated steroid synthesis. The objective of this study was to test the hypothesis that in contrast to etomidate, carboetomidate neither suppresses the adrenocortical response to endotoxemia nor enhances the accompanying production of proinflammatory cytokines.
DESIGN: Animal study.
SETTING: University research laboratory.
SUBJECTS: Male Sprague-Dawley rats.
INTERVENTIONS: For both single and multiple anesthetic dose studies, rats were injected with Escherichia coli lipopolysaccharide immediately followed by a hypnotic dose of etomidate, carboetomidate, or vehicle alone (dimethyl sulfoxide) as a control. For single-dose studies, no additional anesthetic (or vehicle) was administered. For multiple anesthetic dose studies, additional doses of anesthetic (or vehicle) were administered every 15 mins for a total of eight anesthetic (or vehicle) doses.
MEASUREMENTS AND MAIN RESULTS: Plasma adrenocorticotropic hormone, corticosterone, and cytokine concentrations were measured before lipopolysaccharide administration and intermittently throughout the 5-hr experiment. In single anesthetic dose studies, plasma adrenocorticotropic hormone and cytokine concentrations were not different at any time point among the etomidate, carboetomidate, and vehicle groups, whereas plasma corticosterone concentrations were briefly (60-120 mins) reduced in the etomidate group. In multiple anesthetic dose studies, plasma corticosterone concentrations were persistently lower and peak plasma interleukin-1β and interleukin-6 concentrations were higher in the etomidate group vs. the carboetomidate and control groups. Peak plasma interleukin-10 concentrations were similarly elevated in the etomidate and carboetomidate groups vs. the control group.
CONCLUSIONS: Compared with etomidate, carboetomidate produces less suppression of adrenocortical function and smaller increases in proinflammatory cytokine production in an endotoxemia model of sepsis. These findings suggest that carboetomidate could be a useful alternative to etomidate for maintaining anesthesia for a prolonged period of time in patients with sepsis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21926608      PMCID: PMC3242859          DOI: 10.1097/CCM.0b013e31822d7924

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  53 in total

1.  Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function.

Authors:  Joseph F Cotten; Stuart A Forman; Joydev K Laha; Gregory D Cuny; S Shaukat Husain; Keith W Miller; Hieu H Nguyen; Elizabeth W Kelly; Deirdre Stewart; Aiping Liu; Douglas E Raines
Journal:  Anesthesiology       Date:  2010-03       Impact factor: 7.892

2.  Cortisol antiinflammatory effects are maximal at postoperative plasma concentrations.

Authors:  Mark P Yeager; Athos J Rassias; Mary P Fillinger; Anthony W Discipio; Kelly E Gloor; Janice A Gregory; Paul M Guyre
Journal:  Crit Care Med       Date:  2005-07       Impact factor: 7.598

3.  Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock.

Authors:  Michael Oppert; Ralf Schindler; Claudia Husung; Katrin Offermann; Klaus-Jürgen Gräf; Olaf Boenisch; Detlef Barckow; Ulrich Frei; Kai-Uwe Eckardt
Journal:  Crit Care Med       Date:  2005-11       Impact factor: 7.598

Review 4.  Sepsis and septic shock--a review of laboratory models and a proposal.

Authors:  K A Wichterman; A E Baue; I H Chaudry
Journal:  J Surg Res       Date:  1980-08       Impact factor: 2.192

5.  Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.

Authors:  Didier Keh; Thomas Boehnke; Steffen Weber-Cartens; Christina Schulz; Olaf Ahlers; Sven Bercker; Hans-Dieter Volk; Wolf-Dietrich Doecke; Konrad J Falke; Herwig Gerlach
Journal:  Am J Respir Crit Care Med       Date:  2002-11-08       Impact factor: 21.405

6.  Etomidate for procedural sedation in emergency medicine.

Authors:  David R Vinson; David R Bradbury
Journal:  Ann Emerg Med       Date:  2002-06       Impact factor: 5.721

7.  Use of an anesthesia information management system (AIMS) to evaluate the physiologic effects of hypnotic agents used to induce anesthesia.

Authors:  M Benson; A Junger; C Fuchs; L Quinzio; S Böttger; G Hempelmann
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

8.  Should etomidate be used for rapid-sequence intubation induction in critically ill septic patients?

Authors:  Brian T Fengler
Journal:  Am J Emerg Med       Date:  2008-02       Impact factor: 2.469

Review 9.  Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?

Authors:  Alex Dyson; Mervyn Singer
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

10.  Immunodesign of experimental sepsis by cecal ligation and puncture.

Authors:  Daniel Rittirsch; Markus S Huber-Lang; Michael A Flierl; Peter A Ward
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

View more
  9 in total

Review 1.  Pharmacologic Considerations for Pediatric Sedation and Anesthesia Outside the Operating Room: A Review for Anesthesia and Non-Anesthesia Providers.

Authors:  Narjeet Khurmi; Perene Patel; Molly Kraus; Terrence Trentman
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

2.  The pyrrole etomidate analog carboetomidate potently inhibits human 5-HT3A receptor function: comparisons with etomidate and potential implications for emetogenesis.

Authors:  Rooma Desai; Keith W Miller; Douglas E Raines
Journal:  Anesth Analg       Date:  2013-02-11       Impact factor: 5.108

3.  Sedative-hypnotic Binding to 11β-hydroxylase.

Authors:  Ervin Pejo; Xiaojuan Zhou; S Shaukat Husain; Douglas E Raines
Journal:  Anesthesiology       Date:  2016-11       Impact factor: 7.892

4.  Anesthetic drug development: Novel drugs and new approaches.

Authors:  Hovig V Chitilian; Roderic G Eckenhoff; Douglas E Raines
Journal:  Surg Neurol Int       Date:  2013-03-19

Review 5.  Pro/con debate: Is etomidate safe in hemodynamically unstable critically ill patients?

Authors:  Gordon Flynn; Yahya Shehabi
Journal:  Crit Care       Date:  2012-07-19       Impact factor: 9.097

Review 6.  Etomidate derivatives: Novel pharmaceutical agents in anesthesia.

Authors:  Raymond J Malapero; Michael P Zaccagnino; Ethan Y Brovman; Alan David Kaye; Richard D Urman
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Oct-Dec

7.  Minimum infusion rate and adrenocortical function after continuous infusion of the novel etomidate analog ET-26-HCl in rats.

Authors:  Junli Jiang; Bin Wang; Zhaoqiong Zhu; Jun Yang; Jin Liu; Wensheng Zhang
Journal:  PeerJ       Date:  2017-09-04       Impact factor: 2.984

Review 8.  Recent advances in intravenous anesthesia and anesthetics.

Authors:  Mohamed Mahmoud; Keira P Mason
Journal:  F1000Res       Date:  2018-04-17

9.  Stress-induced alterations of social behavior are reversible by antagonism of steroid hormones in C57/BL6 mice.

Authors:  Benedikt Andreas Gasser; Johann Kurz; Walter Senn; Genevieve Escher; Markus Georg Mohaupt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-09-07       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.